Your English writing platform
Discover LudwigSuggestions(1)
Exact(13)
Innovative design features of this trial include randomization to either initial patient-preference of treatment or to a referred care arm in which the primary care provider decided upon care.
Limitations of this trial include inconsistent timing and frequency of platelet counts.
Strengths of this trial include multicenter recruitment, intention-to-treat analysis and randomized double blind design.
Limitations of this trial include the open-label assignment to aspirin and the low event rate.
Limitations of this trial include housing calves in a small pen environment and determining how behavior is related to pain and performance.
Strengths of this trial include: a well-defined study protocol, multicenter, randomized, double-blind, double-dummy design, and complete follow-up.
Similar(47)
The strengths of this trial included the study design and the practical nature of the intervention.
37 The results of this trial included a 6-month PFS of 42% for glioblastoma and 32% for anaplastic glioma.
Therefore, this phase I trial was designed to determine the MTD of weekly gemcitabine with concurrent radiation in patients with locally advanced PC. Eligibility criteria of this trial included Karnofsky performance status of 50 100 points.
The results of this trial, including an examination of clinical, functional and health economic outcomes, will be used to assess the role that this treatment approach may have in recommendations for treatment of depression in Australia and elsewhere.
The design of this trial included two different training cohorts separated by an interval of six months; outcomes in both groups were similar over time and this indicates the essential reproducibility of findings in two different groups with fibromyalgia.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com